What to Expect From Nike Earnings
Nike is scheduled to report its fiscal second-quarter financial results after the markets close on Tuesday.
All Work
Chris Lange
Why Merrill Lynch Raised Both Foot Locker and Finish Line
Foot Locker and Finish Line were riding high in Tuesday's session on upgrades from Merrill Lynch.
pSivida Soars on Positive Late Stage Results
pSivida was leading the bulls in Tuesday’s session on positive results from a late stage trial of Medidur.
Why Investors Are Pushing NetApp to New Lows
NetApp hit a new 52-week low on Tuesday following the announcement of the acquisition of SolidFire.
Acacia Communications Files for IPO
Acacia Communications has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
The 8 Best Performing Dow Stocks of 2015
24/7 Wall St. has put together a look the top eight Dow stocks of 2015 ahead of Christmas this year.
SEC Levies Additional Charges in Pump-and-Dump Scheme
The SEC announced additional fraud charges in a market manipulation case the agency filed last week.
What to Expect From Paychex Earnings
Paychex is scheduled to report its fiscal second-quarter financial results before the markets open on Tuesday.
Meet GE’s Largest Onshore Wind Deal Ever
GE announced that it will provide 43 wind turbines and a full services agreement for two new wind projects in eastern France.
SEC Charges Fraudster With Misleading Investors
The SEC has charged a known securities fraudster with conducting a new scheme since his release from prison by using fake names to solicit investors while hiding his criminal past.
How AVEO Is Winning on Its Newest Licensing Agreement
AVEO Pharmaceuticals was leading the bulls in Monday’s session on news of an exclusive licensing agreement.
Collegium Pharma Announces Secondary Offering
Collegium Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering.
How the Apple and Ericsson Collaboration Could Change the Game
Ericsson and Apple have agreed on a global patent license agreement between the two companies that includes a cross license that covers patents relating to each company.
KemPharm Prepares for Secondary Offering
KemPharm expects to price its 3 million shares around last Thursday's closing price of $18.88, which would value the entire secondary offering at up to more than $65 million.
2 Major Earnings Reports to Look For Before Christmas
24/7 Wall St. has put together a preview of the two major companies reporting their quarterly results this coming week: Nike and Micron Technology.
4 Companies That Destroyed Shareholders This Past Week
24/7 Wall St. has tracked four companies in which shareholders were destroyed last week. Many of these companies have seen their markets caps drop sharply.
5 Retailers That Struck Out for Christmas
24/7 Wall Street has picked out a few retailers that have whiffed this season and contributed to the sliding broad markets.
JPMorgan Wealth Management Subsidiaries Settle with SEC
The SEC has announced that two JPMorgan wealth management subsidiaries have agreed to pay $267 million and admit wrongdoing to settle charges regarding a failure to disclose conflicts of interest to clients.
SecureWorks Files for IPO
SecureWorks has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
ReachLocal Skyrockets on Updated Outlook
ReachLocal raised its outlook for fourth-quarter 2015 adjusted EBITDA and announced a series of strategic actions to improve adjusted EBITDA and its liquidity position in order to provide a foundation for future growth.